K-numberK252548
Device nameAI-Rad Companion Organs RT
ApplicantSiemens Healthcare GmbH
Product codeQKB
Device classClass II
Decision dateApr 10, 2026
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

AI-Rad Companion Organs RT is post-processing software that automatically contours predefined anatomical structures (organs at risk and brain metastases) from CT and MR DICOM images using deep-learning algorithms. The generated contours are intended as input for radiation therapy treatment planning workflows and must be reviewed, edited, and accepted by qualified clinicians using treatment planning systems or interactive contouring applications before clinical use.

Technological characteristics

The subject device adds new MR-brain metastases and MR-brain OAR contouring algorithms while enhancing existing CT and MR pelvis algorithms compared to predicate K242745. Both devices use deep learning, process DICOM CT/MR data, deploy via edge and cloud, output DICOM-RT structure sets, and support any DICOM-compliant treatment planning system. The subject device expands scanner model compatibility for MR beyond Siemens-only data and qualifies algorithms for adult populations with expanded validation datasets.

Test standards cited

ISO 62366-1 (usability engineering), ISO 14971:2019 (risk management), IEC 62304 (medical device software lifecycle), DICOM PS 3.1–3.20 (digital imaging and communications), ISO 15223-1 (medical device symbols), IEC 82304-1 (health software safety), IEC 81001-5-1 (health software and IT system safety), and ISO 20417 (manufacturer information).

Substantial equivalence argument

The subject device is substantially equivalent to predicate K242745 because both use deep-learning algorithms to automatically segment organs from DICOM images for radiation therapy planning and must be used with treatment planning systems for review and editing. Performance validation demonstrates the enhanced CT algorithm and new MR algorithms are equivalent or superior to the predicate and reference devices in segmentation metrics (Dice coefficient, ASSD). The risk analysis and verification/validation data support equivalent safety and effectiveness with no changes to intended use.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →